Development of antiparasitic drugs in the 21st century.
Prospects for discovering new antiparasitic drugs for veterinary medicine in the coming century will be determined by economic, social and scientific factors. Consolidation in the pharmaceutical industry in general, and the animal health industry in particular, changes the business conditions in which drug discovery for veterinary medicine occurs. Social pressures on traditional animal agriculture and companion animal ownership have shifted the interest of animal companies primarily to pet medicine. Antiparasitic drug discovery is more than ever targeted to the most lucrative market segments, but the excellence of available drugs, and the apparent lack of resistance in important parasites, reduces industrial motivation to invest in parasitology. Veterinary parasitologists in academia will still have the chance to interact with their industrial counterparts in the traditional ways of supporting drug discovery and development. Nonetheless, there are many new opportunities to expand the research horizons of veterinary parasitology to strengthen the case for retaining a significant presence in the animal health industry.
Geary
Timothy G
TG
Pfizer Animal Health, 7000 Portage Road, Kalamazoo, MI 49001, USA. timothy.g.geary@pfizer.com
Thompson
David P
DP
D000818:Animals; D000829:Animals, Domestic; D000977:Antiparasitic Agents / Q000737:chemistry / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use; D004351:Drug Resistance; D010273:Parasitic Diseases, Animal / Q000188:drug therapy* / Q000191:economics; D014612:Vaccines / Q000191:economics / Q000276:immunology; D019155:Veterinary Drugs / Q000737:chemistry / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use; D014730:Veterinary Medicine / Q000191:economics* / Q000639:trends*
D000977:Antiparasitic Agents; D014612:Vaccines; D019155:Veterinary Drugs